• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肿瘤微环境的口咽鳞状细胞癌风险分层

Tumor Microenvironment-Based Risk Stratification of Oropharyngeal Squamous Cell Carcinoma.

作者信息

Almangush Alhadi, Jouhi Lauri, Haglund Caj, Hagström Jaana, Mäkitie Antti A, Leivo Ilmo

机构信息

Department of Pathology, University of Helsinki, Helsinki, Finland.

Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.

出版信息

Head Neck. 2025 Feb;47(2):599-605. doi: 10.1002/hed.27945. Epub 2024 Sep 28.

DOI:10.1002/hed.27945
PMID:39340223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11717971/
Abstract

BACKGROUND

Evaluation of the prognostic impact of tumor microenvironment (TME) has received attention in recent years. We introduce a TME-based risk stratification for oropharyngeal squamous cell carcinoma (OPSCC).

MATERIAL AND METHODS

A total of 182 patients treated for OPSCC at the Helsinki University Hospital were included. TME-based risk stratification was designed combining tumor-stroma ratio and stromal tumor-infiltrating lymphocytes assessed in hematoxylin and eosin-stained sections.

RESULTS

In multivariable analysis, TME-based risk stratification associated with poor disease-free survival with a hazard ratio (HR) of 2.68 (95% CI 1.11-6.48, p = 0.029). In addition, the proposed risk stratification was associated with poor disease-specific survival (HR 2.687, 95% CI 1.28-5.66, p = 0.009) and poor overall survival (HR 2.21, 95% CI 1.23-3.99, p = 0.008).

CONCLUSION

Our TME-based risk stratification provides a powerful prognostic tool that can be used in daily treatment planning of OPSCC together with tumor-related prognostic markers.

摘要

背景

近年来,肿瘤微环境(TME)的预后影响评估受到关注。我们介绍一种基于TME的口咽鳞状细胞癌(OPSCC)风险分层方法。

材料与方法

纳入了在赫尔辛基大学医院接受治疗的182例OPSCC患者。基于TME的风险分层设计为结合苏木精-伊红染色切片中评估的肿瘤-基质比和基质肿瘤浸润淋巴细胞。

结果

在多变量分析中,基于TME的风险分层与无病生存期差相关,风险比(HR)为2.68(95%CI 1.11-6.48,p = 0.029)。此外,所提出的风险分层与疾病特异性生存期差(HR 2.687,95%CI 1.28-5.66,p = 0.009)和总生存期差(HR 2.21,95%CI 1.23-3.99,p = 0.008)相关。

结论

我们基于TME的风险分层提供了一种强大的预后工具,可与肿瘤相关预后标志物一起用于OPSCC的日常治疗规划。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c213/11717971/907f900c7569/HED-47-599-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c213/11717971/11c9063c734b/HED-47-599-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c213/11717971/907f900c7569/HED-47-599-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c213/11717971/11c9063c734b/HED-47-599-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c213/11717971/907f900c7569/HED-47-599-g001.jpg

相似文献

1
Tumor Microenvironment-Based Risk Stratification of Oropharyngeal Squamous Cell Carcinoma.基于肿瘤微环境的口咽鳞状细胞癌风险分层
Head Neck. 2025 Feb;47(2):599-605. doi: 10.1002/hed.27945. Epub 2024 Sep 28.
2
Clinical evaluation of tumour-infiltrating lymphocytes as a prognostic factor in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.肿瘤浸润淋巴细胞作为人乳头瘤病毒相关口咽鳞状细胞癌患者预后因素的临床评估。
Histopathology. 2019 Jul;75(1):146-150. doi: 10.1111/his.13873. Epub 2019 Jun 10.
3
Tumor stromal desmoplasia and inflammatory response uniquely predict survival with and without stratification for HPV tumor infection in OPSCC patients.肿瘤基质的促纤维增生和炎症反应能独特地预测口咽鳞状细胞癌(OPSCC)患者在有无HPV肿瘤感染分层情况下的生存率。
Acta Otolaryngol. 2018 Nov;138(11):1035-1042. doi: 10.1080/00016489.2018.1497809. Epub 2019 Feb 8.
4
Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8 T cells.肿瘤浸润 B 细胞通过与 CD8 T 细胞的细胞间相互作用影响口咽鳞状细胞癌的进展。
J Immunother Cancer. 2019 Oct 17;7(1):261. doi: 10.1186/s40425-019-0726-6.
5
LAG-3, TIM-3 and VISTA Expression on Tumor-Infiltrating Lymphocytes in Oropharyngeal Squamous Cell Carcinoma-Potential Biomarkers for Targeted Therapy Concepts.肿瘤浸润淋巴细胞中 LAG-3、TIM-3 和 VISTA 的表达——头颈部鳞状细胞癌的潜在治疗靶点生物标志物。
Int J Mol Sci. 2020 Dec 31;22(1):379. doi: 10.3390/ijms22010379.
6
The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.辅助化疗在手术治疗的p16阳性口咽鳞状细胞癌中的作用
JAMA Otolaryngol Head Neck Surg. 2017 Mar 1;143(3):253-259. doi: 10.1001/jamaoto.2016.3353.
7
Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.人乳头瘤病毒时代切除的口咽鳞状细胞癌强化辅助治疗的护理模式和比较疗效。
JAMA Otolaryngol Head Neck Surg. 2016 Aug 1;142(8):777-88. doi: 10.1001/jamaoto.2016.1162.
8
Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.智利人群口腔和口咽鳞状细胞癌的临床病理及免疫组化评估
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5968-77. eCollection 2014.
9
Clinical significance of overall assessment of tumor-infiltrating lymphocytes in oropharyngeal cancer: A meta-analysis.肿瘤浸润淋巴细胞整体评估在口咽癌中的临床意义:一项荟萃分析。
Pathol Res Pract. 2023 Mar;243:154342. doi: 10.1016/j.prp.2023.154342. Epub 2023 Jan 25.
10
Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.术后口咽癌中p16表达的影响:重新评估传统风险分层的必要性
Jpn J Clin Oncol. 2016 Oct;46(10):911-918. doi: 10.1093/jjco/hyw099. Epub 2016 Jul 29.

本文引用的文献

1
Tumor stroma ratio, tumor stroma maturity, tumor-infiltrating immune cells in relation to prognosis, and neoadjuvant therapy response in esophagogastric junction adenocarcinoma.肿瘤基质比率、肿瘤基质成熟度、与预后相关的肿瘤浸润免疫细胞以及食管胃交界腺癌的新辅助治疗反应。
Virchows Arch. 2025 Feb;486(2):257-266. doi: 10.1007/s00428-024-03755-2. Epub 2024 Feb 21.
2
Tumor-stroma ratio in preoperative biopsies and matched surgical specimens in oral squamous cell carcinoma: Concordance and impact on recurrence-free and overall survival.口腔鳞状细胞癌术前活检与配对手术标本中的肿瘤-间质比:一致性及其对无复发生存率和总生存率的影响
Pathol Res Pract. 2024 Mar;255:155211. doi: 10.1016/j.prp.2024.155211. Epub 2024 Feb 16.
3
Stromal categorization of recurrent oral cancer after salvage surgery is associated with survival rates.
复发性口腔癌挽救性手术后的基质分类与生存率相关。
Eur J Surg Oncol. 2024 Mar;50(3):108009. doi: 10.1016/j.ejso.2024.108009. Epub 2024 Feb 7.
4
Stromal cells in the tumor microenvironment: accomplices of tumor progression?肿瘤微环境中的基质细胞:肿瘤进展的帮凶?
Cell Death Dis. 2023 Sep 4;14(9):587. doi: 10.1038/s41419-023-06110-6.
5
Role of tumor microenvironment in cancer progression and therapeutic strategy.肿瘤微环境在癌症进展和治疗策略中的作用。
Cancer Med. 2023 May;12(10):11149-11165. doi: 10.1002/cam4.5698. Epub 2023 Feb 21.
6
Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment.通过肿瘤微环境的免疫调节来改善头颈部癌症的治疗方法。
Nat Rev Cancer. 2023 Mar;23(3):173-188. doi: 10.1038/s41568-022-00531-9. Epub 2022 Dec 1.
7
The tumour-associated stroma correlates with poor clinical outcomes and immunoevasive contexture in patients with upper tract urothelial carcinoma: results from a multicenter real-world study (TSU-01 Study).肿瘤相关基质与上尿路上皮癌患者不良临床结局和免疫逃避结构相关:多中心真实世界研究(TSU-01 研究)结果。
Br J Cancer. 2023 Jan;128(2):310-320. doi: 10.1038/s41416-022-02049-1. Epub 2022 Nov 17.
8
Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens.喉癌中肿瘤-基质比、新生血管生成与预后。术前活检和配对手术标本的初步研究。
Oral Oncol. 2022 Sep;132:105982. doi: 10.1016/j.oraloncology.2022.105982. Epub 2022 Jun 24.
9
Standardization of the tumor-stroma ratio scoring method for breast cancer research.乳腺癌研究中肿瘤间质比评分方法的标准化。
Breast Cancer Res Treat. 2022 Jun;193(3):545-553. doi: 10.1007/s10549-022-06587-3. Epub 2022 Apr 16.
10
HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management.人乳头瘤病毒相关性口咽癌:流行病学、分子生物学及临床管理。
Nat Rev Clin Oncol. 2022 May;19(5):306-327. doi: 10.1038/s41571-022-00603-7. Epub 2022 Feb 1.